Videos

Remco Munnik, Arcana, details pharma's shift to data-first operations, AI adoption, and robust data stewardship.

The Evolution of Data-First Regulatory Operations

PharmTech spoke with Ian Bilodeau, managing director, Ardena US about how the expanded use of AI has impacted the pharmaceutical industry and the importance of nurturing top talent for a robust workforce.

Industry Outlook 2026: Success through Top Talent, AI Utilization, and Sustainability

Articles

Manish Garg, Hikma, reflects on how AI, resilient supply chains, and smart manufacturing are reshaping pharma today and beyond.

From AI to Smart Factories: How Pharma Is Preparing for 2026

ROSS’s DCB-5 Double Cone Tumble Blender can handle high-density materials and provides repeatable homogeneity and powder blending properties, according to the company. 

Double Cone Tumble Blender Provides Homogeneity in Heavy-Duty Applications

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

In the concluding segment of a multi-part interview, Jason Bryant of ArisGlobal explains how human-in-the-loop and human-on-the-loop are both still relevant in AI implementation in pharma.

HITL and HOTL: An Air Traffic Control Analogy for Agentic AI

Felix Gonzalez, FounderNest, offers a data-driven view of where pharma consolidation is occurring, where capital is being deployed, and how regional M&A strategies differ.

The Global Pharma Merger and Acquisition Landscape

2025 pharma disruption hinged on three themes: political pricing/tariffs, tough quality scrutiny (FDA warnings), and innovation vs. changing standards (patient focus.

Pharma Disruption in 2025: A Recap of Our Top 10 Articles

PharmTech spoke with Campbell Bunce, chief scientific officer, Abzena to find out which trends in 2025 impacted the industry the most.

Industry Outlook 2026: The Impact of Novel Therapies

ArisGlobal’s Jason Bryant continues a video supplement to his series of articles on the adoption and implementation of AI agents.

Full Autonomy Is a ‘No-Go Zone’: Setting Parameters for Agentic AI in Pharma

In this overview, PharmTech takes a look back at significant news in the development and approval of cancer treatment in 2025.

News